amlodipine and benazepril hydrochloride

Generic: amlodipine and benazepril hydrochloride

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amlodipine and benazepril hydrochloride
Generic Name amlodipine and benazepril hydrochloride
Labeler aurobindo pharma limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

amlodipine besylate 5 mg/1, benazepril hydrochloride 10 mg/1

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 65862-583
Product ID 65862-583_a45ec3e8-1d14-4c27-9685-976323df8cad
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202239
Listing Expiration 2026-12-31
Marketing Start 2012-09-05

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa] calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] decreased blood pressure [pe] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65862583
Hyphenated Format 65862-583

Supplemental Identifiers

RxCUI
898342 898346 898350 898353 898356 898359
UNII
864V2Q084H N1SN99T69T

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine and benazepril hydrochloride (source: ndc)
Generic Name amlodipine and benazepril hydrochloride (source: ndc)
Application Number ANDA202239 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
  • 10 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (65862-583-01)
  • 500 CAPSULE in 1 BOTTLE (65862-583-05)
source: ndc

Packages (2)

Ingredients (2)

amlodipine besylate (5 mg/1) benazepril hydrochloride (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a45ec3e8-1d14-4c27-9685-976323df8cad", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898346", "898350", "898353", "898356", "898359"], "spl_set_id": ["99ed4927-9a34-4e8d-8eea-60b63c867d46"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (65862-583-01)", "package_ndc": "65862-583-01", "marketing_start_date": "20120905"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (65862-583-05)", "package_ndc": "65862-583-05", "marketing_start_date": "20120905"}], "brand_name": "Amlodipine and Benazepril Hydrochloride", "product_id": "65862-583_a45ec3e8-1d14-4c27-9685-976323df8cad", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "65862-583", "generic_name": "Amlodipine and Benazepril Hydrochloride", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA202239", "marketing_category": "ANDA", "marketing_start_date": "20120905", "listing_expiration_date": "20261231"}